Latest News
Marshalling Evidence for What Makes Sense in Health Care - Barrons.com
Barron's (subscription required) | 20 hours 11 minutes ago
TWO GOVERNMENT REPORTS TUESDAY OFFERED early hints of the potential industry impact of a $1.1 billion federal program to compare the medical benefit and cost-effectiveness of surgeries, medicines and medical devices. The reports -- by the Institute of Medicine and the Federal Coordinating Council for Comparative Effectiveness Research -- suggest priorities for spending $700 million of the research program's funds under the American Recovery and Reinvestment Act of 2009.... (more)
Glaxo to market anti-diabetic drug Avandia non-exclusively
Financial Express (India), The | 1 day 3 hours 32 minutes ago
GSK Pharma managing director Kal Sundaram said: "We will be launching the drug in the first quarter of the calendar year 2005. The pricing related issues will be finalised soon."... (more)
Allergic reactions to Gardasil uncommon: Study
National Post (Canada) | 1 day 6 hours 13 minutes ago
A study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon... (more)
Recent Around the Net In Media Issues
MediaPost Communications | 1 day 6 hours 17 minutes ago
Unilever has launched a review of most of its media business around the world. The majority of the business in review is handled by Mindshare, which holds the accounts in the U.S., the U.K. and many other European countries. Along with Mindshare, various shops from WPP, Omnicom and Interpublic handle media chores for Unilever and those agency groups are also invited to participate.... (more)
UPDATE 1-J&J says 84.4 pct of Cougar shares tendered
Forbes | 1 day 6 hours 51 minutes ago
* Says about 17.7 mln shares tendered * Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson said about 84.4 percent of the outstanding shares of Cougar Biotechnology Inc were tendered during the initial offering period that ended Thursday and the subsequent offering period for the remaining shares will expire on July 9.... (more)
Smith & Nephew Gets 483 for Complaint Handling
FDAnews | 1 day 6 hours 52 minutes ago
An FDA investigator cited Smith & Nephew for failing to ensure proper complaint-handling procedures in a Form 483 with three observations.... (more)
J&J takes $1bn Elan stake
Financial Times (free content) | 1 day 10 hours 13 minutes ago
Johnson & Johnson, the US healthcare products group, is to take a $1bn ( 600m) minority stake in Elan and commit at least $500m more to help fund development of the lossmaking Irish-American s biotech company s late-stage products for Alzheimer s disease.The US group will acquire an 18.4 per cent stake in Elan, and assume majority control of its two leading experimental Alzheimer s products, which are being developed in a partnership with Wyeth, a large US drugs company.The deal ends mont...... (more)
Global Autoimmune Disease Therapeutics Market To Reach $50B By 2015, According To A New Report By Global Industry Analysts
Bioresearch Online | 1 day 11 hours 23 minutes ago
The global marketplace is characterized by participants such as Abbott Laboratories, Amgen Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Elan Corporation, plc, Eli Lilly And Company, F. Hoffmann-La Roche AG, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Inc., Merck Serono SA, Novartis AG, sanofi-aventis SA, Schering-Plough Corporation, Shire Pharmaceuticals Group plc., Teva Pharmaceuticals Industries Limited, UCB Ph...... (more)
R&D Logic's Unique Products And Services Offering Gaining Momentum With Leading Life Sciences Companies
Bioresearch Online | 1 day 11 hours 23 minutes ago
San Mateo, CA--(Marketwire) - R&D Logic, preferred provider of web based business management software specific to the Life Sciences Industry, today announced five new additions to their Life Sciences Customer Community. Portola Pharmaceuticals, Ambrx Inc., Medivation Inc., Nevro Corporation, and KaloBios Pharmaceuticals have chosen R&D Logic's innovative R&D Select software and service model. These five companies have joined other leading edge biotech, pharmaceutical and medical device compan...... (more)
Johnson & Johnson acquires stake in Ireland's Elan Corp.
Denver Post, The | 1 day 15 hours 34 minutes ago
TRENTON, N.J. - Johnson & Johnson - making a big jump into the risky, but potentially lucrative, field of Alzheimer's disease - is taking a major stake in Irish biopharmaceutical company Elan Corp., investing up to $1.5 billion initially. ... (more)
AFP secures investment, restructures debt
AuntMinnie.com (free registration) | 1 day 15 hours 41 minutes ago
Digital x-ray developer AFP Imaging has received a $1.5 million investment in growth capital and debt restructuring from BioWave Innovations and ComVest Capital.... (more)
Sepracor suffers a pair of setbacks
Boston Globe, The | 1 day 18 hours 9 minutes ago
Sepracor Inc., a Marlborough drug maker, reported a pair of research setbacks. Its experimental drug for depression, SEP-22589, did not reach its main goal in an eight-week mid-stage trial, Sepracor said, because it did not significantly reduce symptoms of depression, compared with a placebo. Also, the Food and Drug Administration placed a hold on two studies of the company s sleep aid, Lunesta. That could hurt its efforts to market Lunesta for use by children. The FDA questioned the relevanc...... (more)
139 Stories | 
RSS Feed
Sign up for FDLI SmartBrief
Latest Blog Postsview more
SC 1st lady says she may forgive husband's affair
Science Blog
Day Off
Corante/In the Pipeline
The BCA "Plethora of evidence": The Fallon Paper
Science Blog
Jordansport2
Science Blog
Job Listingsview more
- Area Center Compliance & Ethics Leader
AstraZeneca - Director, Research, Development and Global Compliance
Astellas - Senior Compliance Counsel
Otsuka
Companies in the news
- Abbott Laboratories
- Acorda Therapeutics Inc.
- AstraZeneca PLC
- BioSante Pharmaceuticals Inc.
- Biogen IDEC Inc.
- Biopure Corp.
- Cell Genesys Inc
- CombinatoRx Inc.
- GE Healthcare
- Geron Corp.
- GlaxoSmithKline plc
- Highmark Inc.
- Johnson & Johnson
- Novavax Inc.
- Pfizer Inc.